Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
5
83%
Ph phase_2
1
17%

Phase Distribution

0

Early Stage

1

Mid Stage

5

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
1(16.7%)
Phase 3Large-scale testing
5(83.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(4)
Other(2)

Detailed Status

Completed4
unknown2

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (16.7%)
Phase 35 (83.3%)

Trials by Status

unknown233%
completed467%

Recent Activity

0 active trials
Showing 5 of 6
completedphase_3

Efficacy and Safety of CKD-501 Added to D150 Plus D745 10mg Therapy in Patients With Type 2 Diabetes

NCT03739125
unknownphase_3

The Efficacy and Safety of CKD-501 Added to D150 Plus D759 Therapy in Patients With Type 2 Diabetes

NCT03641352
unknownphase_3

Efficacy and Safety of CKD-501 Added to D150 Plus D745 25mg Therapy in Patients With Type 2 Diabetes

NCT03627182
completedphase_3

An Evaluation of Glycemic Control Effects of Mono Therapy CKD-501 in Patients With Type 2 Diabetes Mellitus

NCT01001611
completedphase_3

Efficacy and Safety of CKD-501 Versus Pioglitazone When Added to Metformin

NCT01106131
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT03739125Phase 3

Efficacy and Safety of CKD-501 Added to D150 Plus D745 10mg Therapy in Patients With Type 2 Diabetes

Completed
NCT03641352Phase 3

The Efficacy and Safety of CKD-501 Added to D150 Plus D759 Therapy in Patients With Type 2 Diabetes

Unknown
NCT03627182Phase 3

Efficacy and Safety of CKD-501 Added to D150 Plus D745 25mg Therapy in Patients With Type 2 Diabetes

Unknown
NCT01001611Phase 3

An Evaluation of Glycemic Control Effects of Mono Therapy CKD-501 in Patients With Type 2 Diabetes Mellitus

Completed
NCT01106131Phase 3

Efficacy and Safety of CKD-501 Versus Pioglitazone When Added to Metformin

Completed
NCT01030679Phase 2

Evaluate the Glycemic Control of CKD-501 in Type 2 Diabetes Mellitus

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6